New Zealand markets closed

InterCure Ltd. (INCR)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
3.1900-0.1000 (-3.04%)
At close: 04:00PM EDT
3.2100 +0.02 (+0.63%)
After hours: 05:24PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 145.38M
Enterprise value 170.78M
Trailing P/E 15.12
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.52
Price/book (mrq)1.19
Enterprise value/revenue 0.27
Enterprise value/EBITDA 1.24

Trading information

Stock price history

Beta (5Y monthly) 0.24
52-week change 323.64%
S&P500 52-week change 326.27%
52-week high 33.7200
52-week low 30.9900
50-day moving average 32.4875
200-day moving average 31.6786

Share statistics

Avg vol (3-month) 372.45k
Avg vol (10-day) 3110.75k
Shares outstanding 545.57M
Implied shares outstanding 646.43M
Float 829.44M
% held by insiders 135.80%
% held by institutions 111.09%
Shares short (30 Apr 2024) 441.33k
Short ratio (30 Apr 2024) 40.68
Short % of float (30 Apr 2024) 40.17%
Short % of shares outstanding (30 Apr 2024) 40.09%
Shares short (prior month 28 Mar 2024) 490.19k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in ILS.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -17.43%
Operating margin (ttm)-9.04%

Management effectiveness

Return on assets (ttm)-0.11%
Return on equity (ttm)-12.99%

Income statement

Revenue (ttm)355.55M
Revenue per share (ttm)7.80
Quarterly revenue growth (yoy)-30.40%
Gross profit (ttm)N/A
EBITDA 6.68M
Net income avi to common (ttm)-61.96M
Diluted EPS (ttm)-0.3700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)101.33M
Total cash per share (mrq)2.22
Total debt (mrq)195.68M
Total debt/equity (mrq)42.81%
Current ratio (mrq)1.85
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-53.63M
Levered free cash flow (ttm)-58.34M